If you're a biotech founder with proven science... Don't die in the Valley of Death.

Clarity that gets biotech funded

When validation isn’t the problem, clarity is.
We turn your science into a de-risked business narrative, a fundable deck, and a targeted outreach plan that cuts your time to capital.

Modern biotech is ~50 years old.
Because it’s so young, there’s still no shared clarity standard for showing what’s truly de-risked.
That missing standard is why so much proven science never gets funded.

Investors don’t invest
in what they don’t understand

You proved it works
Now you need to prove it’s fundable

Proof ExistsClarity Doesn’tWhy Investors HesitateThe Missing Link

You proved the science works.

But investors don’t follow up.

Truth is, it's not because of your data.

They struggle to see the business in it.

Runway shrinks.

Competitors raise with half your data.

You’re still waiting for someone to “get it.”

They won’t. Clarity has to be engineered.

You’re not ignored because the science is weak.

You’re ignored because the story isn’t clear.

Most founders respond with more slides, more text.

But money flows as a function of de-risked stories.

The problem isn’t visual, it’s structural.

Investors can’t see the leap from validation to de-risked business.

Until that link is clear (scientifically, operationally, and commercially), funding stays stuck.

BioFundable standardizes biotech clarity to shorten the time between
scientific validation and capital.

The 3-step Fundability Engineering™ system

Here’s how we make your science fundable

Fundability Engineering™

Isn’t design or marketing.
It’s the clarity system that turns proven science into something investors instantly understand.Biotech is a long bet. We don’t change that. We make the value, de-risking, and upside clear & traceable. So investors can move faster on what’s already validated.We use investor logic and scientific precision so every slide improves one thing: the chance an investor understands your proof and trusts your path forward.Decode, Design, Deploy shortens the time between validation and capital by turning complex science into a clarity signal investors recognize and rely on.Engineered for biotech, not borrowed from SaaS.

1. Decode
Make Fundability Measurable
2. Design
Engineer Investor Clarity
3. Deploy
Convert Clarity Into Motion
Tap step to see more →
1. Decode2. Design3. Deploy

➤ Find out why investors don’t “get it.”

➢ Score your clarity and risk with the Fundability Score™.

➢ Expose the bottlenecks that block investor belief.


Outcome: You know exactly what’s stopping investors and how to fix it.

➤ Rebuild your story so investors understand it fast.

➢ Create a deck that answers “Why fund this now?”

➢ Translate your data into market logic and risk logic.


Outcome: Investors can model your science, de-risking, and upside instantly.

➤ Turn clarity into investor traction.


➢ Build your target investor landscape.

➢ Tailor scripts and 1:1 support to drive real conversations.


Outcome: You get momentum faster, and every connection stays yours.

Ready to find what’s slowing your funding?

Get your Fundability Score™ and clarity gap breakdown in a quick 15-minute call.

No pitch. No obligation. Just a clarity diagnosis.

Investors move fast when they understand fast

What you actually get with BioFundable

Investors get it instantly
No confusion. No overexplaining. Your value lands on call one.
Your science becomes fundable
Your real de-risked narrative builds trust, the way investors expect.
More investor calls, faster momentum
More replies. More calls. More traction. Your raise accelerates.
No more wasted months rewriting decks
Clarity unlocked. Time saved. Burn reduced. Focus returns to science.
Alignment that lasts beyond the raise
A clear story that guides hiring, deals, and next rounds.

You keep everything

➢ Every deck, script, and investor relationship.➢ Every conversation is yours. We just compress the time to them.➢ You either get momentum, or it's free.

Cut your funding time with BioFundable

From messy (but exciting) lab results to a narrative investors trust.We turn your science into a fundable story. By showing how it reduces scientific, commercial, and operational risk in a way investors can model. All without the months of guessing, rewriting, or confusion that slow founders down.In 15 days or less, you walk away with:

A narrative designed the way investors think, so they get it immediately.
Simple to understand, strong enough to defend, and built around “Why fund this now?”
A curated list matched to your thesis, stage, and science; plus ready-to-send scripts.
We help you through investor calls, follow-ups with new materials, and fix friction as it comes.

Case study results coming soon

Everything included in the Partner Plan

Hiring a designer, a biotech marketer, and an investor advisor easily costs €8000+. And still leaves you stitching the story together yourself.With BioFundable, you get all three in one clarity system, built for biotech. Plus: a long-term partner aligned with your raise, not a freelancer you have to manage.

A quantified score showing how fundable your biotech looks through an investor’s eyes.
A simple map revealing exactly what’s stopping investors from saying yes and how to fix it.
A ready-to-use page that turns every site visit into a potential investor contact.

Total value €8000

Partner Plan
€ 1000

For biotech founders who’ve proven the science and now need investors to see the business behind

No retainers.Flat price.
> Pitch Deck> Fundability Score™
> Fundable Story> Clarity Gap Breakdown
> Tailor Outreach Plan> “For Investors” Landing Page
> Direct 1:1 Support 

30-day money-back guarantee

Only 3 case-study spots open. After they’re filled, full price applies.

If we don’t help you get investor traction, you get your money back

Follow the outreach plan, and if you don’t get a single investor call within 30 days of delivery, we refund 100%.Working with us shouldn’t feel like a gamble.Clarity either moves investors or you don’t pay.

Hey there,Biotech used to be simpler.
If your science was real, chances were someone funded you. Fewer founders, fewer decks, less noise. Clarity wasn’t something you had to engineer.But biotech grew fast and something broke.Founders do the hard part: the scientific validation. Yet they still hear investors say "Too early” and disappear. Not because the data is weak, but because they can’t see the de-risked business inside the science.Meanwhile, investors are drowning in decks, AI slides, and big promises with no real path to risk reduction. Scientists stay in academic packaging. Investors get overwhelmed. Great science dies in the Valley of Death for reasons unrelated to merit.It’s nonsense.Modern biotech is only ~50 years old. There’s no standard way to show proof or translate validation into a de-risked business plan. Everyone present their science differently. The result? High noise, low clarity, slow cycles, missed opportunities.But it doesn’t have to stay this way.If you’ve ever walked out of a pitch thinking “They didn’t get it” even though the science and commercial path are solid, that’s a clarity gap, not a funding gap.Founders shouldn’t lose months rewriting decks. Biotech funding shouldn’t run on guesswork. Money flows as a function of de-risked stories, not noise.That’s why BioFundable exists.We reduce the entropy. We standardize biotech clarity. We turn your proof into a story investors can model quickly, so they understand not just what you’ve built but why it’s fundable now.Our mission is simple: Cut the time between validation and capital so more great science survives long enough to matter.Clarity becomes critical the moment you leave the lab and face investors. Whether you’re raising your first €150k or €750k, you’ll hit clarity gaps. Until you see them, you can’t fix them.If this sounds like what you’re facing, let's jump on a quick call.
Book today to get clarity on what’s keeping investors from saying yes.Limited new spots each cycle. We stay close with every founder until they reach the finish line. Once filled, it’s gone.

Frequently Asked Questions

Yes. If you’ve proven the science and are raising €150k–€750k to hit your next scientific or technical milestone, this is built for you. You have validation. Now you need investors to see the business.

Just your data, any slides or notes, and 1–2 calls so we understand your science and goals. We handle the story, clarity work, deck, and investor logic. We can sign an NDA before reviewing anything.

Yes. Almost no early biotech has traction. Investors fund validation and de-risking long before revenue exists. We show them the business case behind your proof.

Designers make slides and consultants make reports. BioFundable is built for biotech and engineers the clarity investors need to move. You get the story, deck, logic, outreach, and support in one system.

Early and complex science is normal at this stage. We turn your validation into a narrative investors can understand and model. If your proof is real, we can make the story fundable. Book your free fundability call to answer this once and for all.

We match your modality, stage, and needs with investors who fund similar science. No generic lists, only names likely to engage. This keeps outreach focused and effective.

You can choose a flat €1,000 fee, a 1.5% vested equity option, or a blended structure. Equity means we take an active role as your funding partner, not a passive advisor. We can talk through which option fits you. Last 3 case-study spots for full free Partner Plan (claim yours).

We don’t use templates. We start with your proof and map how it reduces scientific, market, and operational risk. Those investor questions are the same across therapeutics, platforms, diagnostics, and synbio. If your validation is real, we can make it legible to capital.

P.S. Don’t let your science die in silence

If investors don’t understand you now, they’ll fund someone else.You’ve already done the hard part, the validation.
Don’t let unclear communication delay your raise another month.Only 3 Partner Plan case-study spots are open.
After that, full price applies.

Why BioFundable can help you

We’re obsessed with one problem: why proven science dies before it gets funded.I’ve lived academia’s complexity and digital marketing’s brutal clarity. Seeing how early biotech doesn’t fail because the science is weak, but because validation isn’t translated into investor logic.Our thesis is straightforward. If investors clearly understood your proof, more breakthroughs would survive. BioFundable exists to make that clarity inevitable.

Why early biotech founders work with us

You’re raising €150k–€750k for your next milestone and investors still don’t “get it.”Not because your data is weak, but because they can’t see the de-risked path inside your science.We turn your validation into a fundable story investors can model. If you’ve proven the science and feel stuck at the communication step, this is built for you.

Why investors resonate with the work we do

Investors are drowning in AI noise, generic decks, and big claims without clear risk mapping.What cuts through now is a story they can underwrite, where scientific, commercial, and operational risks are laid out clearly.We make your proof readable, so investors can trust they’re backing something real, not another overhyped, under-explained pitch.

Ready to find what’s slowing your funding?

Get your Fundability Score™ and clarity gap breakdown in a quick 15-minute call.

No pitch. No obligation. Just a clarity diagnosis.